» Articles » PMID: 37973787

Specific Intracellular Retention of CircSKA3 Promotes Colorectal Cancer Metastasis by Attenuating Ubiquitination and Degradation of SLUG

Overview
Journal Cell Death Dis
Date 2023 Nov 16
PMID 37973787
Authors
Affiliations
Soon will be listed here.
Abstract

Our previous study demonstrated that tumor-suppressor circular RNAs (circRNAs) can be specifically secreted outside of colorectal cancer (CRC) cells within exosomes to maintain tumor cell fitness. However, whether tumor-driving circRNAs can be specifically retained in cells to facilitate tumor progression remains unknown. In this study, circRNA-seq showed that circSKA3 was significantly upregulated in CRC tissues but downregulated in serum samples from CRC patients. In addition, circSKA3 promoted CRC progression in vitro and in vivo and was retained in CRC cells via a specific cellmotif element. Interestingly, the cellmotif element was also the site of interaction of circSKA3 with SLUG, which inhibited SLUG ubiquitination degradation and promoted CRC epithelial-mesenchymal transition (EMT). Moreover, FUS was identified as a key circularization regulator of circSKA3 that bound to the key element. Finally, we designed and synthesized specific antisense oligonucleotides (ASOs) targeting circularization and cellmotif elements, which repressed circSKA3 expression, abolished the SLUG-circSKA3 interaction, and further inhibited CRC EMT and metastasis in vitro and in vivo.

Citing Articles

Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancer.

Zhang N, Wang X, Li Y, Lu Y, Sheng C, Sun Y Commun Biol. 2025; 8(1):77.

PMID: 39825074 PMC: 11748638. DOI: 10.1038/s42003-024-07383-z.


Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities.

Li J, Zhou W, Wang H, Huang M, Deng H MedComm (2020). 2024; 5(12):e70019.

PMID: 39584047 PMC: 11586091. DOI: 10.1002/mco2.70019.


Circular RNA in cancer.

Conn V, Chinnaiyan A, Conn S Nat Rev Cancer. 2024; 24(9):597-613.

PMID: 39075222 DOI: 10.1038/s41568-024-00721-7.


Implications in Cancer of Nuclear Micro RNAs, Long Non-Coding RNAs, and Circular RNAs Bound by PRC2 and FUS.

Swaminathan G, Rogel-Ayala D, Armich A, Barreto G Cancers (Basel). 2024; 16(5).

PMID: 38473229 PMC: 10930775. DOI: 10.3390/cancers16050868.

References
1.
Rinaldi C, Wood M . Antisense oligonucleotides: the next frontier for treatment of neurological disorders. Nat Rev Neurol. 2017; 14(1):9-21. DOI: 10.1038/nrneurol.2017.148. View

2.
Dhuri K, Bechtold C, Quijano E, Pham H, Gupta A, Vikram A . Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development. J Clin Med. 2020; 9(6). PMC: 7355792. DOI: 10.3390/jcm9062004. View

3.
Qu S, Jiao Z, Lu G, Yao B, Wang T, Rong W . PD-L1 lncRNA splice isoform promotes lung adenocarcinoma progression via enhancing c-Myc activity. Genome Biol. 2021; 22(1):104. PMC: 8042710. DOI: 10.1186/s13059-021-02331-0. View

4.
Chen R, Chen X, Xia L, Zhang J, Pan Z, Ma X . N-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat Commun. 2019; 10(1):4695. PMC: 6795808. DOI: 10.1038/s41467-019-12651-2. View

5.
Errichelli L, Dini Modigliani S, Laneve P, Colantoni A, Legnini I, Capauto D . FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat Commun. 2017; 8:14741. PMC: 5379105. DOI: 10.1038/ncomms14741. View